GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $91.3B | -$309M | 60 | 2.33% | Reduced |
|
| 2 |
BlackRock
New York
| $85.8B | +$430M | 66 | 2.53% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $46.5B | -$893M | 63 | 2.62% | Reduced |
|
| 4 |
Lilly Endowment
Indiananapolis,
Indiana
| $35.2B | -$137M | 1 | 100% | Reduced |
|
| 5 |
Fidelity Investments
Boston,
Massachusetts
| $28.2B | -$1.8B | 61 | 2.58% | Reduced |
|
| 6 |
Capital World Investors
Los Angeles,
California
| $27B | -$1.68B | 10 | 5.58% | Reduced |
|
| 7 |
Wellington Management Group
Boston,
Massachusetts
| $24.4B | +$270M | 35 | 4.83% | Increased |
|
| 8 |
T. Rowe Price Associates
Baltimore,
Maryland
| $24.2B | +$606M | 45 | 3.62% | Increased |
|
| 9 |
Geode Capital Management
Boston,
Massachusetts
| $19.4B | +$203M | 65 | 2.52% | Increased |
|
| 10 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $18.8B | -$51.9M | 43 | 16.51% | Reduced |
|
| 11 |
Morgan Stanley
New York
| $17.6B | +$187M | 68 | 1.89% | Increased |
|
| 12 |
Primecap Management
Pasadena,
California
| $15.7B | -$176M | 5 | 13.66% | Reduced |
|
| 13 |
JP Morgan Chase
New York
| $15.5B | -$3.35B | 64 | 1.89% | Reduced |
|
| 14 |
Northern Trust
Chicago,
Illinois
| $12.4B | -$117M | 62 | 2.46% | Reduced |
|
| 15 |
Bank of America
Charlotte,
North Carolina
| $12.4B | +$390M | 60 | 1.27% | Increased |
|
| 16 |
Norges Bank
Oslo,
Norway
| $11.2B | +$568M | 31 | 2.44% | Increased |
|
| 17 |
Bank of New York Mellon
New York
| $11.1B | -$183M | 56 | 2.42% | Reduced |
|
| 18 |
Capital International Investors
Los Angeles,
California
| $9.94B | +$184M | 10 | 2.56% | Increased |
|
| 19 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
| $9.68B | +$29.9M | 6 | 10.03% | Increased |
|
| 20 |
Charles Schwab
San Francisco,
California
| $9.61B | +$816M | 51 | 2.92% | Increased |
|
| 21 |
Invesco
Atlanta,
Georgia
| $7.95B | +$422M | 46 | 2.22% | Increased |
|
| 22 |
Legal & General Group
London,
United Kingdom
| $7.25B | +$39.3M | 47 | 2.59% | Increased |
|
| 23 |
Goldman Sachs
New York
| $6.57B | +$289M | 55 | 1.51% | Increased |
|
| 24 |
Capital Research Global Investors
Los Angeles,
California
| $6.31B | +$339M | 7 | 1.8% | Increased |
|
| 25 |
Amundi
Paris,
France
| $6.3B | +$444M | 27 | 3.39% | Increased |
|